Sign in

CIK 0001427925 · Non-accelerated filer<br>Smaller reporting company

TALPHERA, INC.

Sign in to watch
Ticker
TLPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
412193603
Phone
650-216-3500
Business address
1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
Former names
ACELRX PHARMACEUTICALS INC
  1. 4 Grant or award Director acquired 4,267 shares (grant or award)
  2. 4 Grant or award Director acquired 4,267 shares (grant or award)
  3. 4 Grant or award Director acquired 4,267 shares (grant or award)
  4. 4 Grant or award Director acquired 4,267 shares (grant or award)
  5. 4 Grant or award Director acquired 6,397 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 4 Shares withheld for taxes Chief Medical Officer gave up 4,517 shares (to pay taxes)
  9. 4 Grant or award Chief Medical Officer acquired 15,000 shares (grant or award)
  10. 4 Grant or award Chief Engineering Officer acquired 15,000 shares (grant or award)
  11. 4 Grant or award Chief Financial Officer acquired 15,000 shares (grant or award)
  12. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 213,310 shares at $0.59 ($125,000)
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market buy Chief Medical Officer bought 5,695 shares at an average $1.06 ($6,038)
  15. 4 Shares withheld for taxes Chief Engineering Officer gave up 2,644 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 3,245 shares (to pay taxes)
  17. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 10,575 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Engineering Officer gave up 1,759 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 2,119 shares (to pay taxes)
  20. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 7,032 shares (to pay taxes)

Page 2 of 21 · 404 filings